The Future of TBI Treatment: AI for TBI
The Future of TBI Treatment: AI for TBI
Owl Therapeutics
Who we are.
Mission: To develop and market novel neurotherapeutics for traumatic brain injury (TBI) and associated conditions like post-traumatic epilepsy (PTE) and Alzheimer’s disease (AD).
​
Vision: To pioneer artificial intelligence (AI)- and diagnostic-powered brain health pipelines to improve the lives of patients.
​
Owl is the first clinical-stage, AI- and diagnostic-powered biopharmaceutical company focused on advancing neurotherapeutics for TBI and associated conditions. The company is set to embark on Phase 2 trials for its lead asset OWL-1410.
Want to join us or partner? ​​​Reach out to book a meeting to explore opportunities to help our courageous patients.​
